Philips Adepoju

Seed Investor at NVIDIA

📍 United States🔄 Updated September 2026💼 1 investments📅 10 years investing🗓 Last invested Dec 2016
Angel investor🌍 United States
1
Total investments
1
Early stage
0
Mid stage
0
Late stage
10y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Seed Investor
Dec 2016
At Flo, our purpose is to build a better future for female health. We are the world’s leading period and ovulation tracker, empowering over 400 million women globally to take control of their health. With 77 million monthly active users, including 25% of US women, Flo has become a trusted partner in womens health. As the first European femtech unicorn, following a $230M Series C in July 2024, were proud to lead the way in innovation and investment in womens health. With over 100+ medical experts, Flo is committed to supporting women at every stage of their health journey, from menstruation to conception, pregnancy, and menopause. We provide curated cycle and ovulation tracking, tailored health insights, daily bite-sized visual content, and a private community for users to share their questions and concerns. Flo addresses critical challenges in women’s health by: *Expanding access: Through partnerships like UNFPA, Flo provides free Premium access to up to 1 billion women in 66 countries, with 17 million subscriptions donated, helping bridge healthcare disparities. *Improving health literacy: By delivering accurate, accessible information and daily insights, Flo empowers millions to better understand their health and make informed decisions. *Advancing womens health research: Collaborating with leading institutions, Flo contributes to evidence-based women’s health research. In a world where womens health data is increasingly vulnerable, Flo is dedicated to providing a safe and secure platform. Recognized for its commitment to privacy, Flos Anonymous Mode feature was named one of TIMEs Best Inventions of 2023 and a finalist for Fast Companys 2023 World Changing Ideas Awards. Anonymous Mode allows users to access Flos health features without associating personal information with their health data, setting a new industry standard for reproductive health data privacy.
Experience · 1 entries
All (1)
Investments (1)
2016
Seed Investor
Dec 2016
At Flo, our purpose is to build a better future for female health. We are the world’s leading period and ovulation tracker, empowering over 400 million women globally to take control of their health. With 77 million monthly active users, including 25% of US women, Flo has become a trusted partner in womens health. As the first European femtech unicorn, following a $230M Series C in July 2024, were proud to lead the way in innovation and investment in womens health. With over 100+ medical experts, Flo is committed to supporting women at every stage of their health journey, from menstruation to conception, pregnancy, and menopause. We provide curated cycle and ovulation tracking, tailored health insights, daily bite-sized visual content, and a private community for users to share their questions and concerns. Flo addresses critical challenges in women’s health by: *Expanding access: Through partnerships like UNFPA, Flo provides free Premium access to up to 1 billion women in 66 countries, with 17 million subscriptions donated, helping bridge healthcare disparities. *Improving health literacy: By delivering accurate, accessible information and daily insights, Flo empowers millions to better understand their health and make informed decisions. *Advancing womens health research: Collaborating with leading institutions, Flo contributes to evidence-based women’s health research. In a world where womens health data is increasingly vulnerable, Flo is dedicated to providing a safe and secure platform. Recognized for its commitment to privacy, Flos Anonymous Mode feature was named one of TIMEs Best Inventions of 2023 and a finalist for Fast Companys 2023 World Changing Ideas Awards. Anonymous Mode allows users to access Flos health features without associating personal information with their health data, setting a new industry standard for reproductive health data privacy.